Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$23 Mln
P/E Ratio
--
P/B Ratio
3.61
Industry P/E
24.53
Debt to Equity
0.05
ROE
-1.15 %
ROCE
--
Div. Yield
0 %
Book Value
0.08
EPS
-0.12
CFO
$-45.12 Mln
EBITDA
$-54.72 Mln
Net Profit
$-61.32 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
India Globalization Capital (IGC)
| -15.57 | -14.03 | -16.53 | -41.63 | -31.17 | -10.17 | -4.29 |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
India Globalization Capital (IGC)
| 19.82 | -12.50 | -67.35 | -37.18 | 147.62 | 125.00 | -71.81 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 44.89 | 7,381.63 | 37.59 | 21.8 | |
| 165.27 | 5,936.91 | 21.13 | 13.21 | |
| 144.08 | 5,656.67 | 20.01 | 27.01 | |
| 76.74 | 6,837.38 | 25.33 | 31.45 |
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to... Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland. Read more
President, CEO & Director
Mr. Ram Mukunda
President, CEO & Director
Mr. Ram Mukunda
Headquarters
Potomac, MD
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of India Globalization Capital Inc (IGC) stood at $ 12 Mln as on 31-Dec-24
The share price of India Globalization Capital Inc (IGC) is $0.28 (NYSE) as of 17-Apr-2025 16:25 EDT. India Globalization Capital Inc (IGC) has given a return of -31.17% in the last 3 years.
India Globalization Capital Inc (IGC) has a market capitalisation of $ 23 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of India Globalization Capital Inc (IGC) is 3.61 times as on 17-Apr-2025, a 50% premium to its peers’ median range of 2.41 times.
Since, TTM earnings of India Globalization Capital Inc (IGC) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the India Globalization Capital Inc (IGC) and enter the required number of quantities and click on buy to purchase the shares of India Globalization Capital Inc (IGC).
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
The CEO & director of Mr. Ram Mukunda. is India Globalization Capital Inc (IGC), and CFO & Sr. VP is Mr. Ram Mukunda.
There is no promoter pledging in India Globalization Capital Inc (IGC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
738
|
|
|
690
|
|
|
589
|
|
|
561
|
| India Globalization Capital Inc. (IGC) | Ratios |
|---|---|
|
Return on equity(%)
|
-124.61
|
|
Operating margin(%)
|
-510.36
|
|
Net Margin(%)
|
-712.7
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of India Globalization Capital Inc (IGC) was $0 Mln.
$0.00
(
